An Integrated Framework for Reporting Clinically Relevant Biomarkers From Paired Tumor/Normal Genomic and Transcriptomic Sequencing Data in Support of Clinical Trials in Personalized Medicine

doi 10.1142/9789814644730_0007

Related search